BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CgA AND Treatment
70 results:

  • 1. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
    Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
    Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. EMT Molecular Signatures of pancreatic Neuroendocrine Neoplasms.
    Venugopal A; Michalczyk A; Khasraw M; Ackland ML
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362433
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Anticancer Effects of the
    Tosoc JPS; Nuñeza OM; Sudha T; Darwish NHE; Mousa SA
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641577
    [No Abstract]    [Full Text] [Related]  

  • 4. Use of Chromogranin A for Monitoring Patients With pancreatic Neuroendocrine Neoplasms.
    Yu F; Fu J; Zhang C; Wu W; Ai S; Yao X; Meng Q; Huang Y; Lu G; Wang F; Qu W
    Pancreas; 2021 Jul; 50(6):882-889. PubMed ID: 34347728
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Synthetic Makaluvamine Analogs Decrease c-Kit Expression and Are Cytotoxic to Neuroendocrine Tumor Cells.
    Aburjania Z; Whitt JD; Jang S; Nadkarni DH; Chen H; Rose JB; Velu SE; Jaskula-Sztul R
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33114525
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
    Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
    Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Blood Molecular Genomic Analysis Predicts the Disease Course of Gastroenteropancreatic Neuroendocrine Tumor Patients: A Validation Study of the Predictive Value of the NETest®.
    van Treijen MJC; van der Zee D; Heeres BC; Staal FCR; Vriens MR; Saveur LJ; Verbeek WHM; Korse CM; Maas M; Valk GD; Tesselaar MET
    Neuroendocrinology; 2021; 111(6):586-598. PubMed ID: 32492680
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for pancreatic Neuroendocrine Tumors.
    Partelli S; Andreasi V; Muffatti F; Schiavo Lena M; Falconi M
    Ann Surg Oncol; 2020 Oct; 27(10):3928-3936. PubMed ID: 32253675
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Application of non-invasive low-intensity pulsed electric field with thermal cycling-hyperthermia for synergistically enhanced anticancer effect of chlorogenic acid on PANC-1 cells.
    Lu CH; Kuo YY; Lin GB; Chen WT; Chao CY
    PLoS One; 2020; 15(1):e0222126. PubMed ID: 31995555
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
    Bodei L; Kidd MS; Singh A; van der Zwan WA; Severi S; Drozdov IA; Malczewska A; Baum RP; Kwekkeboom DJ; Paganelli G; Krenning EP; Modlin IM
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):895-906. PubMed ID: 31838581
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The impact of surgery for metastatic pancreatic neuroendocrine tumor: a contemporary evaluation matching for chromogranin a level.
    Concors SJ; Sinnamon AJ; Ecker BL; Metz DC; Vollmer CM; Fraker DL; Roses RE
    HPB (Oxford); 2020 Jan; 22(1):83-90. PubMed ID: 31239188
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells.
    Lu CH; Chen WT; Hsieh CH; Kuo YY; Chao CY
    PLoS One; 2019; 14(5):e0217676. PubMed ID: 31150487
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells.
    Herrera-Martínez AD; Feelders RA; de Herder WW; Castaño JP; Gálvez Moreno MÁ; Dogan F; van Dungen R; van Koetsveld P; Hofland LJ
    Horm Cancer; 2019 Jun; 10(2-3):107-119. PubMed ID: 31102172
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors.
    Herrera-Martínez AD; van den Dungen R; Dogan-Oruc F; van Koetsveld PM; Culler MD; de Herder WW; Luque RM; Feelders RA; Hofland LJ
    Endocr Relat Cancer; 2019 Jun; 26(6):585-599. PubMed ID: 30939452
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
    Pavel ME; Phan AT; Wolin EM; Mirakhur B; Liyanage N; Pitman Lowenthal S; Fisher GA; Vinik AI;
    Oncologist; 2019 Apr; 24(4):463-474. PubMed ID: 30355775
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis.
    Rossi RE; Ciafardini C; Sciola V; Conte D; Massironi S
    Pancreas; 2018; 47(10):1249-1255. PubMed ID: 30325865
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax).
    Betge J; Chi-Kern J; Schulte N; Belle S; Gutting T; Burgermeister E; Jesenofsky R; Maenz M; Wedding U; Ebert MP; Haertel N
    BMC Cancer; 2018 Jul; 18(1):747. PubMed ID: 30021548
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Rectal Neuroendocrine Tumor with Synchronous pancreatic Metastasis: A Case Report.
    Masuoka Y; Furukawa D; Yazawa N; Izumi H; Yamada M; Mashiko T; Saito G; Okada K; Tanaka A; Suzuki T; Sadahiro S; Hirabayashi K; Nakagohri T
    Tokai J Exp Clin Med; 2018 Jul; 43(2):38-44. PubMed ID: 29961930
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.
    Rossi RE; Rausa E; Cavalcoli F; Conte D; Massironi S
    Scand J Gastroenterol; 2018; 53(7):835-842. PubMed ID: 29726295
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
    Corsello A; Di Filippo L; Massironi S; Sileo F; Dolcetta Capuzzo A; Gemma M; Carlucci C; Cusini C; Colombo B; Dallatomasina A; Franchi GM; Corti A; Manzoni MF
    PLoS One; 2018; 13(5):e0196858. PubMed ID: 29723285
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.